International position paper on febuxostat

Clin Rheumatol. 2010 Aug;29(8):835-40. doi: 10.1007/s10067-010-1457-8. Epub 2010 Apr 17.


This position paper aims to clarify the presumed place of febuxostat in the management of gout patients. Since this novel xanthine oxidase inhibitor is now available, an international group of gout experts decided to formulate an international consensus statement. This statement presents the place for this new xanthine oxidase inhibitor in the treatment of gout which may contribute to optimize treatment of gout patients in Europe and worldwide.

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Febuxostat
  • Gout / drug therapy*
  • Gout Suppressants / therapeutic use*
  • Humans
  • International Cooperation
  • Thiazoles / therapeutic use*
  • Treatment Outcome
  • Xanthine Oxidase / antagonists & inhibitors


  • Gout Suppressants
  • Thiazoles
  • Febuxostat
  • Xanthine Oxidase